MEDICINAL AND OTHER PRODUCTS AND HUMAN AND ANIMAL TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES - MEMORANDUM FROM A WHO MEETING

Authors
AGUZZI A BARBARA J BROWN P BUDKA H DIRINGER H DORMONT D FLANAGAN P HEESCHEN W HOPE J HORNLIMANN B KENNEY K MASTERS C MACNAUGHTON MR POCCHIARI M ROHWER RG SAFAR J SOMOGYI A TATEISHI J TAYLOR D VANDUIJN CM WILESMITH JW WILL R WISHER M ASHER D CUESTA JD FEEK C HASEBE K HORAUD F LOWER J MINOR P NANDAPALAN P PAVLOV A PEREZ AC RICKETTS M VICARI G VANAKEN WG BEAL R MENACHEARONSON D BRADLEY R BAILEY A CHALUMEAU HP GARLAND A BROOKS W SCHRIEBER R SPRENGERS E ANDJAPARIDZE AG BOLIS CL EMMANUEL JC GRIFFITHS E HEYMANN DL KABOYO W MESLIN FX MIYAGAWA S MARROQUIN AP SCHUDEL A ZEIDLER M
Citation
A. Aguzzi et al., MEDICINAL AND OTHER PRODUCTS AND HUMAN AND ANIMAL TRANSMISSIBLE SPONGIFORM ENCEPHALOPATHIES - MEMORANDUM FROM A WHO MEETING, Bulletin of the World Health Organization, 75(6), 1997, pp. 505-513
Citations number
10
Journal title
Bulletin of the World Health Organization → ACNP
ISSN journal
00429686
Volume
75
Issue
6
Year of publication
1997
Pages
505 - 513
Database
ISI
SICI code
0042-9686(1997)75:6<505:MAOPAH>2.0.ZU;2-D
Abstract
The report in March 1996 of 10 human cases of a novel form of Creutzfe ldt-Jakob disease in the United Kingdom, and its possible link to the agent that causes bovine spongiform encephalopathy (BSE), raises many questions about the safety of animal-derived products and by-products entering the food chain or being used in medicine. This Memorandum upd ates the preventive measures put forward in 1991 to minimize the risks associated with the use of bovine-derived materials in medicinal prod ucts and medical devices.